Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    38.00 (3.12%)
Bid:
1,240.00
Ask:
1,258.00
Spread: 18.00 (1.452%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Full Year Trading Update

27 May 2026 07:00

RNS Number : 7634F
Cohort PLC
27 May 2026
 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

 

 

 

27 May 2026

 

 

 

 

COHORT PLC

("Cohort" or "the Group")

 

Full Year Trading Update

 

Revenue and adjusted operating profit ahead of expectations

 

Cohort, the independent technology Group, today provides a trading update for its financial year ended 30 April 2026.

 

Summary

· Revenue of £303m and adjusted operating profit of c.£36m, both subject to audit, ahead of market expectations.

· Strong order intake of around £313m (2025: £284m), once again exceeding in-year revenue.

· Closing order book at a new record of c.£620m (30 April 2025: £615m).

· The order book underpins c.£253m of current market revenue expectations for the new financial year (30 April 2025: £230m) or c.80% cover.

· Closing net funds of £2.9m, (2025: £5.3m); new five-year bank facility of £175m in place.

 

FY26 year-end update

 

Cohort achieved 12% revenue growth and a net margin of 11.9% (2025: 10.2%). Both revenue and adjusted operating profit were ahead of market expectations.

 

The Group's Communications and Intelligence division saw growth in revenue to £159m (2025: £125.4m) and delivered a net margin of around 20% (2025: 16.8%). This result included a full year contribution from EM Solutions and was the driver of the Group's improved performance. The Sensors and Effectors division reported relatively flat revenue of £144m (2025: £147.1m) with a net margin of around 7% (2025: 8.6%). The lower net margin reflected continued prudent trading on ELAC's Italian sonar contract and the sale of SEA's high margin transport business in June 2025. All three businesses in the Sensors and Effectors division delivered positive trading profit in the year, but the low net margin remains below our mid-term target.

 

Cohort ended the year with net funds of around £2.9m, reflecting a strong cash performance in H2, a significant turnaround from the £32.5m net debt position at the H1 reporting point. This was slightly below our expectations due to some significant receipts slipping into the first quarter of 2026/27 financial year with over £6m being received in early May.

 

Order intake was c.10% higher than last year, with particularly good performances from EID, MASS and EM Solutions, within Communications and Intelligence, and at Chess and SEA in Sensors and Effectors. Total order intake again exceeded revenue for the year (2025: 1.1x) following a number of important wins during the year, including the award of a €42.3m contract to EID to deliver Integrated Communication Systems to the Portuguese Navy. As a result, the closing order book was around £620m, a record high, with on-order revenue extending out to the mid-2030's.

 

 

Notice of FY26 results

 

These are expected to be released on 15 July 2026.

 

Andrew Thomis, Chief Executive of Cohort, said:

 

"Cohort performed strongly in 2025/26, exceeding market expectations. Following another year of strong order intake, our closing order book has reached a new record level, and we have encouraging prospects for further orders.

 

"I'm particularly pleased with the strong maiden full year contribution from EM Solutions. The business has made good progress in capturing opportunities for growth and collaboration with other Cohort subsidiaries.

 

"Our strong balance sheet and liquidity provides a robust platform from which to continue to invest in the business while considering further targeted acquisitions.

 

"The high level of order cover provides confidence in a strong 2026/27 financial year."

 

Market expectations

 

The consensus market expectations for the full year ended 30 April 2026 were £34.7m of adjusted operating profit on £293.9m of revenue, and adjusted earnings per share of 58.9 pence.

 

 

 

ENDS

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

Kellie Young, Group Head of Investor Communications and Events

Investec Bank Plc (Financial Adviser, Nominated Adviser, and Corporate Broker)

020 7597 5970

Carlton Nelson, Christopher Baird, Charlotte Young

MHP

07817 458804

Reg Hoare, Ollie Hoare, Hugo Harris

cohort@mhpgroup.com

 

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total over 1,600 core staff there and at its other operating company sites across the UK, Australia Germany, and Portugal.

 

The group is split into two segments - Communications and Intelligence, and Sensors and Effectors:

 

Communications and Intelligence

 

· EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

 

· EM Solutions designs, assembles, tests, and supports satellite communications on-the-move terminals for defence and government customers. It also provides high-end broadband radio transceivers and other RF Subsystems such as low noise receivers and solid-state high-power transmitters for defence and commercial customers. Acquired by Cohort in January 2025. www.emsolutions.com.au

 

· MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services, and training support. Acquired by Cohort in August 2006. www.mass.co.uk

 

· MCL designs, sources, and supports advanced electronic and surveillance technology for UK end users including the MoD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

Sensors and Effectors

 

· Chess Dynamics offers surveillance, tracking and fire-control systems to the defence and security markets. Chess has been part of the Group since December 2018. www.chess-dynamics.com

 

· ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.de 

 

· SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in October 2007. www.sea.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVEETIRFIR
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.